Health insurance stocks tumbled Tuesday after the Trump administration proposed a lower-than-expected increase in Medicare Advantage (MA) payments for 2027. Companies like ELV, HUM, and UNH saw significant drops, reflecting investor concern. The proposed 0.09% increase is far below the roughly 5% increase analysts had anticipated, sparking a sell-off across the sector.

The Centers for Medicare & Medicaid Services (CMS) cited various factors influencing the payment rate, including underlying costs and quality bonus payments. MA plans, offered by private companies, provide services bundled from original Medicare. Analysts at Truist and Mizuho expressed disappointment, suggesting the rule could delay earnings growth for companies heavily reliant on MA.

This unexpected announcement has created uncertainty for investors. While the CMS proposal is subject to change before the final announcement in April, the initial reaction indicates a negative impact on the health insurance sector. Analysts are now assessing the potential impact on future earnings and growth projections.

Managed care organizations have become a large part of the healthcare system, and investors closely watch the government's actions related to payments. The final rule in April will be key. Investors will be watching the final payment rates and assessing how these changes will impact the profitability of these plans.